Literature DB >> 581782

Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.

U Thadani, C Davidson, W Singleton, S H Taylor.   

Abstract

We compared the immediate effects of five beta-adrenoreceptor-blocking agents in 16 patients with stable angina pectoris. Acute dose-response studies showed that all five drugs improved exercise tolerance and reduced ST-segment depression, heart rate and blood pressure by a similar degree in comparison with a placebo (P less than 0.01). Near maximum improvement in exercise tolerance occurred when the acute cumulative oral dose had reached 160 mg for propranolol and oxprenolol, 200 mg for metoprolol and tolamolol and 400 mg for practolol. When these drugs were administered as a single doses, increase in walking time before the development of angina and reduction in ST-segment depression, heart rate and systolic blood pressure all occurred within one hour and persisted for eight hours--effects markedly different from the response to a placebo (P less than 0.01). These data show that non-cardioselective agents (propranolol and oxprenolol), cardioselective agents (practolol, metoprolol and tolamolol), as well as drugs with intrinsic sympathomimetic activity (oxprenolol and practolol), were equally effective in the treatment of angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 581782     DOI: 10.1056/NEJM197904053001402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  The structure of celiprolol.

Authors:  N Kumar; C Strohbeck; H L Ammon
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

Review 2.  Relief of Ischemia in Ischemic Cardiomyopathy.

Authors:  Francesco Moroni; Zachary Gertz; Lorenzo Azzalini
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

3.  Current status of Beta blocker therapy.

Authors:  J D Gray
Journal:  Can Fam Physician       Date:  1980-05       Impact factor: 3.275

4.  The influence of atherosclerosis on the mechanical responses of human isolated coronary arteries to substance P, isoprenaline and noradrenaline.

Authors:  G Berkenboom; M Depierreux; J Fontaine
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

5.  Anaesthetic problems associated with the treatment of cardiovascular disease: II. Beta-adrenergic antagonists.

Authors:  D C Chung
Journal:  Can Anaesth Soc J       Date:  1981-03

6.  Left ventricular function and beta-blockers: does intrinsic sympathomimetic activity have any influence during chronic therapy?

Authors:  R J Northcote; M B Cooke; D Ballantyne
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 7.  Formulary considerations in selection of beta-blockers.

Authors:  K C Yedinak
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

8.  Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.

Authors:  R Lochan; B Silke; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

9.  Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.

Authors:  G R Jones; M A Mir
Journal:  Br Heart J       Date:  1981-11

10.  Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.

Authors:  M J Bowles; N S Khurmi; M J O'Hara; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.